{"retracted":false,"update":{"timestamp":1470009600000,"doi":"10.1016/j.freeradbiomed.2016.07.017","type":"err"},"doi":"10.1016/j.freeradbiomed.2016.03.009","journal":"Free Radical Biology and Medicine","publisher":"Elsevier BV","title":"Corrigendum to ‘L-Ascorbic acid can abrogate SVCT-2-dependent cetuximab resistance mediated by mutant KRAS in human colon cancer cells’"}
